ARCUS platform

DURHAM, N.C., May 27, 2026 Precision BioSciences announced new and late-breaking clinical data from the ELIMINATE-B study evaluating PBGENE-HBV,...

Durham, North Carolina, U.S. | April 15, 2026 Precision BioSciences has announced a significant clinical and regulatory milestone with...